Will stock surge before Earnings results? NASDAQ:LMPX, NASDAQ:SFET, NASDAQ:MACK, NYSE:MDLY

This post was originally published on this site

LMP AUTOMOTIVE EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NASDAQ:LMPX)

LMP Automotive last announced its earnings results on March 25th, 2021. The reported ($0.15) earnings per share for the quarter. The company had revenue of $4.01 million for the quarter. LMP Automotive has generated $0.00 earnings per share over the last year. LMP Automotive has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, August 13th, 2021 based off prior year’s report dates.

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN LMP AUTOMOTIVE? (NASDAQ:LMPX)

Wall Street analysts have given LMP Automotive a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but LMP Automotive wasn’t one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat’s top stock picks here.

SAFE-T GROUP (NASDAQ SFET) EARNINGS HISTORY BY QUARTER (NASDAQ:SFET)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN SAFE-T GROUP? (NASDAQ:SFET)

Wall Street analysts have given Safe-T Group a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Safe-T Group wasn’t one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat’s top stock picks here.

MERRIMACK PHARMACEUTICALS (NASDAQ MACK) EARNINGS HISTORY BY QUARTER (NASDAQ:MACK)

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN MERRIMACK PHARMACEUTICALS? (NASDAQ:MACK)

Wall Street analysts have given Merrimack Pharmaceuticals a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Merrimack Pharmaceuticals wasn’t one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat’s top stock picks here.

MEDLEY MANAGEMENT EARNINGS ESTIMATES AND ACTUALS BY QUARTER (NYSE:MDLY)

Medley Management last announced its earnings data on March 31st, 2021. The asset manager reported ($0.24) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by $0.04. The firm had revenue of $8.48 million for the quarter. Medley Management has generated $0.00 earnings per share over the last year. Medley Management has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, August 13th, 2021 based off prior year’s report dates.

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN MEDLEY MANAGEMENT? (NYSE:MDLY)

Wall Street analysts have given Medley Management a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Medley Management wasn’t one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat’s top stock picks here.